NEW YORK CITY–( ORGANIZATION CORD)– Erlanger, a nationally-acclaimed, multi-hospital wellness system, introduced today a critical collaboration with Qventus, the market’s premier supplier of AI-based treatment procedures automation software program, to drive tactical medical development and rise individual accessibility to one of the most innovative, minimally intrusive da Vinci treatments. This financial investment in Qventus’ Surgical Development Remedy belongs to Erlanger’s dedication to leveraging the most recent AI modern technology and best-in-class devices
发布者：Dr.Durant，转转请注明出处：https://robotalks.cn/erlanger-and-qventus-partner-to-expand-robotic-access-and-create-additional-or-capacity/
